Search results
PROMOTED
Start date:
Jan 21, 2026
Pacemaker implantation remains one of the most common complications after TAVI. In this webinar, chaired by Prof Rafal Dworakowski (Abbott APAC Medical Affairs Director, Singapore, SG) and Dr Simon Lam (Queen Mary Hospital, Hong Kong, HK), leading specialists will focus on the anatomy of the conduction system anatomy, highlight key pre-procedural planning considerations, and share proven…
View more
Added:
1 year ago
EuroPCR 25 - A meta-analysis of the individual patient data from the PROTECTED TAVR and BHF PROTECT-TAVI studies show TAVI with cerebral embolic protection (CEP) may reduce the rate of disabling stroke compared to TAVI without CEP.We are joined by Prof Rajesh Kharbanda (Oxford Radcliffe Hospitals NHS Trust, Oxford, UK) to discuss outcomes from a meta-analysis investigating TAVI with or without…
View more
Added:
9 months ago
Explore the intricate challenges of TAVR-in-TAVR procedures with Dr Frederick Welt, addressing the growing need for repeat transcatheter interventions as TAVR expands to younger patient populations.This comprehensive presentation, part of the Complex Cases track, examines the technical and clinical considerations when managing structural valve deterioration in patients with existing transcatheter…
View more
Added:
9 months ago
Master the technical complexities of TAVR-in-TAVR procedures with Dr Mohamed MarwanThis essential presentation tackles implanting a transcatheter valve within a previously implanted, failing TAVR device. As first-generation TAVR patients return for treatment, Dr Marwan provides the critical knowledge needed to master these increasingly common complex procedures.Key technical considerations…
View more
Added:
1 week ago
Dr Virag Kushwaha (Eastern Heart Clinic, New South Wales, AU) joins us to discuss 30-day outcomes of valve-in-valve transcatheter aortic valve replacement using the Navitor system in patients with failed surgical aortic bioprosthetic valves.As the population of patients with ageing surgical bioprostheses continues to grow, valve-in-valve TAVR has become an increasingly important treatment pathway…
View more
Added:
1 week ago
EuroPCR 2026 – Prof Howard Herrmann (University of Pennsylvania School of Medicine, Philadelphia, PA, US) joins us to discuss three-year outcomes from the SMART trial, evaluating self-expanding versus balloon-expandable transcatheter aortic valve replacement in patients with a small aortic annulus and symptomatic severe native aortic stenosis.This prospective, international, randomised controlled…
View more
Added:
1 year ago
ACC 2025 - Primary findings from EARLY-TAVR show the benefit of early TAVR intervention was consistent across biomarker subgroups.Dr Brian Lindman (Vanderbilt University Medical Center, Nashville, US) joins us onsite at ACC 2025 to discuss findings from the primary biomarker analysis from the EARLY TAVR trial (NCT03042104; Edwards Lifesciences). The analysis investigated cardiac biomarkers in…
View more
Added:
11 months ago
New York Valves 2025 - Dr Sunny Goel (Mount Sinai Hospital, New York, US) joins us to discuss the current devices and strategies that are used for embolic protection and stroke prevention in transcatheter aortic valve replacement (TAVR). Dr Goel highlights the lack of strong guidelines in the field and shares findings from recent studies investigating embolic protection devices.Interview…
View more
Added:
11 months ago
New York Valves 2025 - Prof Ole De Backer (Rigshospitalet, Copenhagen, DK) joins us to discuss the current landscape of transcatheter aortic valve replacement (TAVR) in 2025. Prof De Backer highlights the recent trends in current TAVR research and shares his anticipations and hopes for the future of the procedure.Interview Questions:1. What does the TAVR landscape look like in 2025, and how has…
View more
Added:
1 year ago
TCT Conference 2024 - Safety and efficacy outcomes of transcatheter aortic valve replacement (TAVR) in addition to optimal heart failure therapy (OHFT) compared to OHFT alone in patients with heart failure and moderate aortic stenosis.Dr Nicolas M Van Mieghem (Erasmus University Medical Center, Rotterdam, NL) joins us onsite at TCT Conference to discuss the findings from TAVR UNLOAD (NCT02661451)…
View more